Notice of Change to Award Information in PAR-19-242, Paul Calabresi Career Development for Clinical Oncology (K12 Clinical Trial Optional)
Notice Number:
NOT-CA-20-088

Key Dates

Release Date:

July 22, 2020

Related Announcements

PAR-19-242 - Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of the Notice is to inform the extramural community about a change to the Award Information in PAR-19-242, "Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)".

Through this Notice of Change to PAR-19-242, NCI will provide funds to defray the travel costs to attend a K-12 community conference.

The following sections of PAR-19-242 have been impacted by this Notice:

Part 2. Full Text of Announcement, Section II. Award Information, Other Program Related Expenses

Currently reads:

In years other than year 1 of a new award, if applicable and justified, up to $26,000 per year may be requested to defray the costs of a consultant, Program Administrator, and/or program assistant with responsibilities directly associated with the institutional career development program; salaries must be commensurate with institutional policy for similar positions and specifically identified and justified. When applicable, this expense must be itemized in Section B of the R&R Budget.

Travel for key persons and Advisory Committee members must be justified as specifically required by the proposed program and must not duplicate items generally available for similar programs at the applicant institution. These expenses must be itemized in Section D of the R&R Budget.

Has been amended to read (in italics)

In years other than year 1 of a new award, if applicable and justified, up to $26,000 per year may be requested to defray the costs of a consultant, Program Administrator, and/or program assistant with responsibilities directly associated with the institutional career development program; salaries must be commensurate with institutional policy for similar positions and specifically identified and justified. When applicable, this expense must be itemized in Section B of the R&R Budget.

Travel for key persons and Advisory Committee members must be justified as specifically required by the proposed program and must not duplicate items generally available for similar programs at the applicant institution. These expenses must be itemized in Section D of the R&R Budget.

Travel funds at the rate of $1,500 per person will be provided to defray the travel costs to attend a K-12 community conference (a regular conference voluntarily organized by an institution(s) with an NCI K12 award for the purpose of gathering K12 Scholars and Mentors for exchange of knowledge, career development and networking). Each year, one Mentor and about half the total Scholars will be supported. It is anticipated that a Scholar will attend this conference in their first year of support, and if applicable again in their third year. Each Program would decide who would receive this funding giving priority to Scholars who have not previously received it and based on the Scholar’s ability to travel at the time of the conference as well as standing in the program, and other Scholars/mentors/program leaders could attend using funds from their institution as available.

All other aspects of PAR-19-242 remain unchanged.

Inquiries

Please direct all inquiries to:

Mark Damico, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5639
Email: damicomw@mail.nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices